Dwight H. Owen

Dwight H. Owen's research focuses on the treatment of advanced non-small cell lung cancer (NSCLC), including immunotherapy (drugs that help the immune system attack cancer), targeted therapies for tumors with specific genetic mutations (like ROS1), and clinical trial design. A notable thread in recent work involves using deep-learning analysis of serial CT scans as a biomarker to predict patient survival and treatment response earlier in the course of care, extending to other cancers like kidney and colorectal cancer.

Publication output grew substantially over the last decade, rising sharply from roughly a dozen papers per year before 2019 to a peak of over 150 in 2023, with continued high output (60-75 per year) in 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026